Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mind Medicine (MindMed) Inc
MNMD
Alternate Symbol(s):
N.MMED.WS
|
N.MMED
|
N.MMED.WA
|
N.MMED.WR
Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen...
drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MNMD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(3)
•••
GoldmemberBC
X
View Profile
View Bullboard History
Comment by
GoldmemberBC
on Jul 14, 2022 10:35pm
RE:RE:Is there any hope?
100%, same with all his digital currency pumps.....
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 12, 2022 11:38pm
InMed Better Opp than MindMed
https://youtu.be/AssQAYmOo0I
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Comment by
Bullknit101
on Jul 12, 2022 11:35pm
RE:Is there any hope?
Looks like O'Leary made his money on this one and there's no more meat left on the bone.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 01, 2022 5:30pm
New Press Release - Mindmed Announces Voting Results for Annual General and Special Meeting
NEW YORK, June 1, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), announces the voting results of the Company's annual general and special meeting of shareholders held on June 1, 2022 (the "Meeting").Election of DirectorsThe five...
read article.
(37)
•••
MrVerbatim9800
X
View Profile
View Bullboard History
Post by
MrVerbatim9800
on Jun 01, 2022 10:15am
Two price targets $10.00 and $7.00. This stock is a buy.
EOM
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 01, 2022 8:00am
New Press Release - MindMed to Participate in the Jefferies Global Healthcare Conference
NEW YORK, June 1, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that Robert Barrow, Chief Executive Officer and...
read article.
(8)
•••
SilverSpewn
X
View Profile
View Bullboard History
Post by
SilverSpewn
on May 31, 2022 12:09pm
Is there any hope?
Look at the chart of the new CFO's former company Avalo Therapeutics... also there has been $20M in insider selling recently according to the Ark Insider report... heaven help us.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 23, 2022 7:30am
New Press Release - MindMed Appoints Schond L. Greenway as Chief Financial Officer
NEW YORK, May 23, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, announced the appointment of Schond L. Greenway as Chief Financial...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 19, 2022 7:30am
New Press Release - MindMed Reports Topline Data From Phase 1 Trial of MM-110 in Development for the Treatment of Opioid Withdrawal
- Positive safety and tolerability results support the advancement of MM-110 and guide the Phase 2a dose design in individuals undergoing supervised opioid withdrawal -- Phase 2a trial remains on track to initiate in Q2 2022 -NEW YORK, May 19, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc...
read article.
(120)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on May 18, 2022 3:52pm
RE:RE:Why so quiet on here
And under $1 for 30 days likely results in a NASDAQ delisting.
(9675)
•••
Larrymartin77
X
View Profile
View Bullboard History
Comment by
Larrymartin77
on May 18, 2022 5:19am
RE:Gonna see it keep rocking
(17)
•••
maoae7
X
View Profile
View Bullboard History
Comment by
maoae7
on May 17, 2022 6:07pm
RE:Very positive results
Yes positive. I took LSD many times in the seventies, A good chemist can make LSD 25 in a few days for a low cost. I sold my MindMed shares because i don't think pharma can make big money with LSD
...more
(105)
•••
Normandt1965
X
View Profile
View Bullboard History
Post by
Normandt1965
on May 11, 2022 6:22am
Very positive results
Trial results: 65% showing reduction in anxiety lasting up to 16 weeks. Out of the total participants, 40% had comorbity with depression. The placebo group only had a 6% response rate. The study was
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on May 02, 2022 3:41pm
Kevin "Mr. Wonderful" O'Leary speaks about Mindmed
https://youtu.be/FDYQw-5nr8s
(28)
•••
BryceCanada
X
View Profile
View Bullboard History
Post by
BryceCanada
on Apr 28, 2022 5:03pm
Thoughts on MNMD vs AWKN?
https://youtu.be/lUQiFawTyNg
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project